Dieter Glebe，吉森，德国——HBV相关实验室及人物介绍系列

bigben446

Dieter Glebe，吉森大学，德国——HBV相关实验室及人物介绍系列
Dieter Glebe主要研究乙肝早期进入

[1].        Jacobsen, K.S., et al., Identification of valid reference genes for microRNA expression studies in a hepatitis B virus replicating liver cell line. BMC Res Notes, 2016. 9: p. 38.
[2].        Montalbano, R., et al., Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. Oncotarget, 2016.
[3].        Kucinskaite-Kodze, I., et al., New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen. Virus Res, 2016. 211: p. 209-21.
[4].        Graumann, F., et al., Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in  Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes. PLoS One, 2015. 10(12): p. e0146099.
[5].        Pleckaityte, M., et al., Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. BMC Biotechnol, 2015. 15: p. 85.
[6].        Seiz, P.L., et al., Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany suggest a major role of hepatitis B e antigen expression in disease severity and  progression. Int J Med Microbiol, 2015. 305(7): p. 663-72.
[7].        Cerino, A., et al., A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity. PLoS One, 2015. 10(4): p. e0125704.
[8].        Maasoumy, B., et al., Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. Clin Microbiol Infect, 2015. 21(6): p. 606.e1-10.
[9].        Abdelnabi, Z., et al., Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine. PLoS One, 2014. 9(12): p. e113821.
[10].        Yousif, M., et al., Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis, 2014. 29: p. 125-32.
[11].        Glebe, D. and A. Geipel, Selected phenotypic assays used to evaluate antiviral resistance and viral fitness of hepatitis B virus and its variants. Intervirology, 2014. 57(3-4): p. 225-31.
[12].        Glebe, D. and A. Konig, Molecular virology of hepatitis B virus and targets for antiviral intervention. Intervirology, 2014. 57(3-4): p. 134-40.
[13].        Konig, A., et al., Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. J Hepatol, 2014. 61(4): p. 867-75.
[14].        Yousif, M., et al., Analysis of ultra-deep pyrosequencing and cloning based sequencing of the basic core promoter/precore/core region of hepatitis B virus using newly developed bioinformatics tools. PLoS One, 2014. 9(4): p. e95377.
[15].        Churin, Y., et al., Pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background. PLoS One, 2014. 9(3): p. e90608.
[16].        Drexler, J.F., et al., Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci U S A, 2013. 110(40): p. 16151-6.
[17].        Yousif, M., et al., Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis, 2013. 13: p. 328.
[18].        Glebe, D. and C.M. Bremer, The molecular virology of hepatitis B virus. Semin Liver Dis, 2013. 33(2): p. 103-12.
[19].        Bremer, C.M., et al., N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol, 2011. 55(1): p. 29-37.
[20].        Wittkop, L., et al., Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation. Cell Microbiol, 2010. 12(7): p. 962-75.
[21].        Rabe, B., D. Glebe and M. Kann, Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events. J Virol, 2006. 80(11): p. 5465-73.
[22].        Glebe, D., Attachment sites and neutralising epitopes of hepatitis B virus. Minerva Gastroenterol Dietol, 2006. 52(1): p. 3-21.
[23].        Schmitt, S., et al., Structure of pre-S2 N- and O-linked glycans in surface proteins from different genotypes of hepatitis B virus. J Gen Virol, 2004. 85(Pt 7): p. 2045-53.
[24].        Schmitt, S., et al., Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem, 1999. 274(17): p. 11945-57.